当前位置:首页 - 行情中心 - 大唐药业(920433) - 财务分析 - 资产负债表

大唐药业

(920433)

  

流通市值:8.72亿  总市值:13.18亿
流通股本:1.69亿   总股本:2.56亿

资产负债表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
流动资产:
  货币资金29,712,104.1219,479,569.8419,793,224.2513,849,831.32
  交易性金融资产5,388,469.725,369,717.727,427,670.435,466,614.41
  应收票据及应收账款29,616,763.9433,536,869.351,358,623.1962,337,012.73
  其中:应收票据5,720,731.746,631,364.261,011,540.914,337,360.03
        应收账款23,896,032.226,905,505.0450,347,082.2857,999,652.7
  应收款项融资33,207,953.1125,296,419.06-117,929.18
  预付款项5,002,105.834,488,411.2910,199,796.8410,318,270.23
  其他应收款合计781,428.64252,339.95409,257.21545,618.9
  存货52,262,227.3450,571,914.2253,289,990.8855,999,479.99
  一年内到期的非流动资产147,012.65293,458.49--
  其他流动资产-860,709.52762,966.64248,495.35
  流动资产合计156,118,065.35140,149,409.37163,241,529.41178,883,252.11
非流动资产:
  长期应收款---506,526.37
  固定资产349,978,558.38363,653,158.43375,819,969.35382,044,261.34
  在建工程4,657,497.654,114,484.911,842,424.461,296,148.31
  使用权资产1,685,177.11,731,564.471,777,951.841,824,339.21
  无形资产20,789,701.520,959,257.1520,383,928.3120,535,318.26
  长期待摊费用3,376,661.733,018,515.063,516,420.413,845,049.27
  递延所得税资产8,609,260.159,145,610.4411,985,308.588,948,360.92
  其他非流动资产2,479,585.21,141,875.092,742,509.141,967,013.77
  非流动资产合计391,576,441.71403,764,465.55418,068,512.09420,967,017.45
  资产总计547,694,507.06543,913,874.92581,310,041.5599,850,269.56
流动负债:
  短期借款88,849,718.7275,384,627.5183,718,313.2874,447,605.44
  应付票据及应付账款26,410,883.4732,714,867.526,858,221.5429,218,768.7
        应付账款26,410,883.4732,714,867.526,858,221.5429,218,768.7
  合同负债14,966,703.2519,217,874.4516,426,545.317,184,857.78
  应付职工薪酬6,567,403.275,358,351.12,604,534.364,790,293.07
  应交税费2,792,021.171,593,511.46113,876.45448,203.57
  其他应付款合计5,029,289.914,341,434.55,597,274.325,125,836.79
  一年内到期的非流动负债283,982.15283,982.15523,671.02523,671.02
  其他流动负债4,072,688.185,608,175.252,676,028.595,612,308.06
  流动负债合计148,972,690.12144,502,823.92138,518,464.86137,351,544.43
非流动负债:
  租赁负债278,939.93414,571.79307,127.62435,740.04
  长期应付款407,249.94407,249.94407,249.94407,249.94
  递延收益18,061,266.3518,467,416.7619,811,310.4220,215,464.39
  递延所得税负债297,929.1261,826.21294,991.35294,776.16
  非流动负债合计19,045,385.3219,551,064.720,820,679.3321,353,230.53
  负债合计168,018,075.44164,053,888.62159,339,144.19158,704,774.96
所有者权益(或股东权益):
  实收资本(或股本)255,919,681255,919,681255,919,681255,919,681
  资本公积128,961,697.08128,961,697.08128,961,697.08128,961,697.08
  盈余公积33,361,972.9433,361,972.9433,361,972.9433,361,972.94
  未分配利润-38,566,919.4-38,383,364.723,727,546.2922,902,143.58
  归属于母公司股东权益合计379,676,431.62379,859,986.3421,970,897.31441,145,494.6
  股东权益合计379,676,431.62379,859,986.3421,970,897.31441,145,494.6
  负债和股东权益合计547,694,507.06543,913,874.92581,310,041.5599,850,269.56
公告日期2026-04-292026-04-292025-10-292025-08-27
审计意见(境内)标准无保留意见
TOP↑